Bookrunners Stifel and JMP Securities selling 9,090,909 common shares
By Devika Patel
Knoxville, Tenn., July 28 – Argos Therapeutics, Inc. said it priced a $50 million public offering of stock with a $3.15 million greenshoe. The deal was announced Wednesday.
The company will sell 9,090,909 common shares at $5.50 per share, a 14.86% discount to the July 27 closing share price of $6.46.
Investors will also receive warrants for 6,818,181 shares.
Stifel and JMP Securities are the bookrunners and Needham is a lead manager.
Settlement is expected Aug. 2.
The biopharmaceutical company is based in Durham, N.C.
| Issuer: | Argos Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $50 million
|
| Greenshoe: | $3.15 million
|
| Shares: | 9,090,909
|
| Price: | $5.50
|
| Warrants: | For 6,818,181 shares
|
| Bookrunners: | Stifel and JMP Securities
|
| Lead manager: | Needham
|
| Co-managers: | FBR and Roth Capital Partners
|
| Announcement date: | July 27
|
| Pricing date: | July 28
|
| Settlement date: | Aug. 2
|
| Stock symbol: | Nasdaq ARGS
|
| Stock price: | $6.46 at close July 27
|
| Market capitalization: | $141.75 million
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
